Rigel Pharmaceuticals Inc (RIGL)
25.04
+0.73
(+3.00%)
USD |
NASDAQ |
Nov 21, 16:00
25.11
+0.07
(+0.28%)
After-Hours: 20:00
Rigel Pharmaceuticals Profit Margin (Quarterly): 22.46% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 22.46% |
| June 30, 2024 | -2.80% |
| March 31, 2024 | -27.92% |
| December 31, 2023 | 2.06% |
| September 30, 2023 | -20.23% |
| June 30, 2023 | -24.55% |
| March 31, 2023 | -51.92% |
| December 31, 2022 | 2.73% |
| September 30, 2022 | -84.95% |
| June 30, 2022 | -45.25% |
| March 31, 2022 | -164.0% |
| December 31, 2021 | -110.9% |
| September 30, 2021 | -97.26% |
| June 30, 2021 | -52.62% |
| March 31, 2021 | 48.75% |
| December 31, 2020 | -104.3% |
| September 30, 2020 | -77.08% |
| June 30, 2020 | -109.7% |
| March 31, 2020 | 38.10% |
| December 31, 2019 | -111.7% |
| September 30, 2019 | -55.09% |
| June 30, 2019 | -198.0% |
| March 31, 2019 | -139.4% |
| December 31, 2018 | 8.53% |
| September 30, 2018 | -488.5% |
| Date | Value |
|---|---|
| June 30, 2018 | -1.43K% |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | -1.96K% |
| June 30, 2017 | |
| March 31, 2017 | -427.3% |
| December 31, 2016 | -519.7% |
| September 30, 2016 | -601.8% |
| June 30, 2016 | -157.5% |
| March 31, 2016 | -347.3% |
| December 31, 2015 | -148.6% |
| September 30, 2015 | -51.34% |
| June 30, 2015 | -268.4% |
| March 31, 2015 | -835.3% |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | -293.2% |
| September 30, 2013 | |
| June 30, 2013 | -1.63K% |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | -1.65K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-164.0%
Minimum
Mar 2022
48.75%
Maximum
Mar 2021
-48.55%
Average
-48.58%
Median
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 3.10% |
| Return on Invested Capital | 12.00% |
| Gross Profit Margin (Quarterly) | 85.49% |
| Operating Margin (Quarterly) | 25.41% |
| Return on Net Operating Assets | 6.71% |